Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism

ARAZ Ö., Ucar E., Yalcin A., KELERCİOĞLU N., MERAL M., GÖRGÜNER A. M., ...Daha Fazla

CLINICAL RESPIRATORY JOURNAL, cilt.10, sa.2, ss.163-167, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/crj.12196
  • Dergi Adı: CLINICAL RESPIRATORY JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.163-167
  • Anahtar Kelimeler: acute pulmonary embolism, fibrinolytic therapy, Hs-CRP, reperfusion duration, C-REACTIVE PROTEIN, VENOUS THROMBOEMBOLISM, EMERGENCY-DEPARTMENT, BIOMARKERS, MANAGEMENT, RISK
  • Atatürk Üniversitesi Adresli: Evet

Özet

BackgroundThe diagnostic utility of novel biomarkers in patients with suspected pulmonary embolism (PE) is still under investigation. While many studies emphasize that high serum levels of high-sensitivity C-reactive protein (Hs-CRP) has a moderate relation with PE, few studies show that Hs-CRP can be used to predict the outcome of the treatment.